Please wait...

NEWS AND EVENTS

  • 10/04/2021
    A Look Back: MatMaCorp's technology successfully tests for lemur species in Madagascar

    MatMaCorp was able to provide a complete solution for the unique challenge of identifying endangered Lemurs in Madagascar using the Solas 8, MagicTip, and C-SAND technologies.

    Learn more

  • 08/16/2021
    Performance Evaluation of COVID-19 2SF Assay

    Learn more

  • 04/30/2021
    Pandemic Pushes Handheld qPCR Devices Closer to Commercialization

    From the pen to the clinic, MatMaCorp is developing handheld real time PCR systems for the point of care.

    Learn more

  • 03/30/2021
    News Release: MatMaCorp Announces MYRTA, a New Hand-Held Real-Time PCR Device for POC and OTC Molecular Diagnostics

    MYRTA is capable of simultaneous PCR amplification and real-time fluorescent detection, with cycle threshold (Ct) values, in under an hour

    Learn more

  • 02/23/2021
    News Release: MatMaCorp's COVID-19 2SF RNA Test Effective in Detecting Variants

    MatMaCorp’s COVID-19 2SF RNA test detects a highly conserved RNA-dependent RNA polymerase (RdRp) gene of SARS-CoV-2 and received FDA EUA to be performed on company’s Solas 8 portable platform

    Learn more

  • 01/12/2021
    News Release: FDA Issues Emergency Use Authorization for MatMaCorp's COVID-19 2SF RNA Test for the Detection of SARS-CoV-2

    MatMaCorp received NIH RADx funding to scale COVID-19 testing for rural and agricultural communities

    Learn more

  • 10/07/2020
    Lincoln firm gets federal funds aimed at boosting nation's testing capacity

    MatMaCorp’s Solas 8 portable testing machine is designed to improve on-site testing capabilities of hospital labs in rural areas. The company recently received a share of a $129.3 million federal award to further development, part of a National Institutes of Health effort to bolster testing capacity in the United States.

    Learn more

  • 09/02/2020
    News Release: NIH Selects MatMaCorp to Deliver COVID-19 Testing in US

    MatMaCorp’s COVID-19 platform recognized by NIH. Receives funding for manufacturing and scale up of Solas 8 devices and 2SF tests to support testing in rural communities.

    Learn more

  • 04/20/2020
    News Release: MatMaCorp Appoints Alexi Wellman to the Board of Directors

    MatMaCorp welcomes Alexi Wellman who brings extensive leadership experience and expertise in corporate finance and accounting to our Board of Directors

    Learn more

Archives